CIK: 0001884931 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $338,335 (95.7% shares, 4.3% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ABUS | ARBUTUS BIOPHARMA CORP | 13,343,228 | $60,578 | 17.9% | $2.43 | +51.2% | COM | 03879J100 |
| ROIV | ROIVANT SCIENCES LTD | 3,532,000 | $53,439 | 15.8% | $10.37 | +19.3% | SHS | G76279101 |
| GNW | GENWORTH FINL INC | 3,701,960 | $32,947 | 9.7% | $5.95 | +38.6% | COM SHS | 37247D106 |
| SPY | SPDR S&P 500 ETF TR | 40,000 | $26,647 | 7.9% | — | — | Put | 78462F103 |
| JOYY | JOYY INC | 404,944 | $23,734 | 7.0% | $39.81 | — | ADS REPSTG COM A | 46591M109 |
| OABI | OMNIAB INC | 14,223,658 | $22,758 | 6.7% | $2.16 | -15.3% | COM | 68218J103 |
| CDZI | CADIZ INC | 3,986,822 | $18,818 | 5.6% | $3.56 | -1.8% | COM NEW | 127537207 |
| BALY | BALLYS CORPORATION | 1,343,243 | $14,910 | 4.4% | $10.06 | 0.0% | COMMON STOCK | 05875B304 |
| TDAY | GANNETT CO INC | 3,585,406 | $14,808 | 4.4% | $3.52 | +14.1% | COM | 36472T109 |
| — | OPKO HEALTH INC | 9,350,000 | $14,394 | 4.3% | $1.61 | — | NOTE 3.750% 1/1 | 68375NAG8 |
| LQDA | LIQUIDIA CORPORATION | 607,409 | $13,812 | 4.1% | $11.94 | +81.7% | COM NEW | 53635D202 |
| GLD | SPDR GOLD TR | 27,000 | $9,598 | 2.8% | — | — | Call | 78463V107 |
| SGRY | SURGERY PARTNERS INC | 371,000 | $8,028 | 2.4% | $22.23 | +0.4% | COM | 86881A100 |
| IWM | ISHARES TR | 33,000 | $7,985 | 2.4% | $241.96 | — | RUSSELL 2000 ETF | 464287655 |
| OPK | OPKO HEALTH INC | 4,900,000 | $7,595 | 2.2% | $1.37 | +0.2% | COM | 68375N103 |
| KG | KESTREL GROUP LTD | 160,916 | $4,395 | 1.3% | $24.35 | +8.8% | COM | G5260K102 |
| VATE | INNOVATE CORP | 743,000 | $3,633 | 1.1% | $7.29 | -28.7% | COM NEW | 45784J303 |
| NNAVW | NEXTNAV INC | 47,264 | $256 | 0.1% | $1.42 | — | *W EXP 99/99/999 | 65345N114 |